197 related articles for article (PubMed ID: 15151486)
1. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
Vuorio AF; Kovanen PT; Gylling H
Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
[TBL] [Abstract][Full Text] [Related]
3. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
4. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
[TBL] [Abstract][Full Text] [Related]
5. Management of a patient with a null low-density lipoprotein receptor mutation: a case report.
Kolovou GD; Dedoussis GV; Anagnostopoulou KK; Hatzigeorgiou GCh; Salpea KD; Choumerianou DM; Rammos S; Mikhailidis DP; Cokkinos DV
Angiology; 2006 Dec-2007 Jan; 57(6):729-32. PubMed ID: 17235114
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia: current treatment and advances in management.
Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
Miltiadous G; Saougos V; Cariolou M; Elisaf MS
Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia.
Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G
Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834
[No Abstract] [Full Text] [Related]
9. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
Geiss HC; Schwandt P; Parhofer KG
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
[TBL] [Abstract][Full Text] [Related]
10. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C
Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459
[TBL] [Abstract][Full Text] [Related]
11. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
[TBL] [Abstract][Full Text] [Related]
13. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
[TBL] [Abstract][Full Text] [Related]
14. [Is detection and treatment of familial hypercholesterolemia indicated in children?].
Bakker HD; Wiegman A; Defesche JC; Kastelein JJ
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
Hemphill LC
J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
[TBL] [Abstract][Full Text] [Related]
16. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
17. Aortic calcifications in familial hypercholesterolemia: potential role of the low-density lipoprotein receptor gene.
Alrasadi K; Alwaili K; Awan Z; Valenti D; Couture P; Genest J
Am Heart J; 2009 Jan; 157(1):170-6. PubMed ID: 19081415
[TBL] [Abstract][Full Text] [Related]
18. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
19. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
Vuorio A; Kovanen PT
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
[TBL] [Abstract][Full Text] [Related]
20. Clinical observations and treatment of pediatric homozygous familial hypercholesterolemia due to a low-density lipoprotein receptor defect.
Huang CH; Chiu PC; Liu HC; Lu YH; Huang JK; Charng MJ; Niu DM
J Clin Lipidol; 2015; 9(2):234-40. PubMed ID: 25911080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
